Today Baywater Healthcare UK Limited (“Baywater”) – part of Sapio Group, an international healthcare and industrial gases company with annual revenues of approximately €1 billion – announces that it has completed the acquisition of Medical Gas Solutions Ltd (“MGS”), a UK based supplier of a mixture of nitrous oxide and oxygen which supplies certain public healthcare entities as well as a number of private customers (the “Transaction”). MGS is also a supplier to Baywater for oxygen cylinder filling.
The Transaction supports Baywater’s long-term planning with regard to its cylinder filling services, strengthening its operational resilience and ensuring service continuity, with a focus on safe and resilient service for customers and patients. The Transaction is also consistent with Sapio Group’s broader strategic priorities and RISE growth plan, aimed to support the Group’s focus on developing reliable and high-quality healthcare services.
MGS will continue to operate and serve its customers as a separate entity from its existing locations. There are therefore no changes to day-to-day customer contacts or operational arrangements as a result of completion.
Adam Sullivan, CEO of Baywater Healthcare said: “At Baywater, our focus is always on ensuring that patients and customers receive safe, reliable and uninterrupted care. Bringing MGS into the Group strengthens our ability to deliver on that commitment while creating opportunities for future growth and innovation. We are delighted to welcome the MGS team and look forward to building a successful future together.”
The financial terms of the transaction have not been disclosed.
About Baywater Healthcare UK Limited
Baywater Healthcare is a leading UK provider of home based respiratory care and the country’s largest provider of NHS Home Oxygen Services. Working in partnership with the NHS, Baywater delivers a growing range of specialist respiratory and long term condition services designed to improve outcomes and help patients live more independently.
About Sapio Group
Founded in 1922 in Monza, Italy, Sapio is an Italian multinational group owned 51% by the Dossi and Colombo families and 49% by Air Products and Chemicals (USA). The Group operates in the industrial gases, medical gases, and homecare sectors across Italy, France, the United Kingdom, Germany, Slovenia, Turkey, Spain, Portugal, employing more than 3,500 people and revenues of €1 billion.
In addition to supplying medical gases to hospitals and healthcare facilities, Sapio provides medical devices for oxygen therapy, mechanical ventilation, artificial nutrition, telemonitoring, sleep medicine, assisted home hemodialysis, advanced pharmaceuticals, integrated homecare services, and cryotherapy.
In the field of homecare, the Group also implements the most effective solutions to enhance patients’ quality of life, ensures greater adherence to prescribed therapies, providing care to over 400,000 patients throughout Europe each year.
Media contacts:
Sapio Group
Valentina Semeraro
Change & External Communications Manager
+39 3496304825
Baywater Healthcare
Jack Brookes
Marketing Communications Specialist
